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• Whole-genome sequencing will be used to identify the genetic 
mutations responsible for: 
◦ the evolution of antibiotic resistance
◦ differences between small and large colony variants that affect 
their apparent synergetic relationship.
• Assessment of other replicates for potential changes in biofilm 
formation.
• Examination of a potential relationship between colony morphology 
and biofilm formation.
• Investigation of any relationship between biofilm formation and 
antibiotic resistance.
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Klebsiella pneumoniae is a gram-negative nosocomial pathogen and 
causative agent of many hospital acquired infections. K. pneumoniae infections 
have become increasingly of interest due to the rise of hypervirulent variants 
and multidrug resistant strains. Modeling how antibiotic resistance evolves in 
K. pneumoniae will allow us to better understand exactly how the bacterium 
acquires resistance to various antibiotics. A previous experiment in our lab 
exposed a strain of K. pneumoniae to low but increasing concentrations of the 
antibiotic cephalothin. As a result, the strain evolved to be mucoid with 
elongated cellular morphology and resistant to multiple antibiotics. This study 
aimed to repeat the same experimental approach with multiple cultures, to 
determine if different genomic mutations could result in the same endpoint of 
antibiotic resistance. Five cultures of K. pneumoniae 43816 were exposed to 
increasing amounts of the antibiotic cephalothin over a 14-day period. After the 
14 day experiment, cultures were assayed for changes in antibiotic 
susceptibility, colony, and cellular-level morphology. Preliminary results 
indicate evolved resistance to cephalothin and tetracycline, but not kanamycin. 
Further, alterations in the colony morphology have been noted with a mix of 
small and large colony phenotypes. This variation of colony morphology in the 
adapted population may indicate different genetic mutations that correspond to 
these large and small colony variants. Current work is determining the 
relationship between colony morphology and antibiotic resistance.
• Identify evolutionary characteristics that K. pneumoniae develops in 
response to increasing antibiotic resistance in vitro.
• Characterize various morphology changes in K. pneumoniae in response to 
in vitro antibiotic resistance development.
• Determine how the in vitro development of cephalothin resistance in K. 
pneumoniae affects susceptibility to other antibiotics and biofilm formation.
Klebsiella pneumoniae (ATCC 43816) was grown in low but increasing 
concentrations of cephalothin over a period of 14 days to induce the 
development of antibiotic resistance. Five replicates (labeled A, B, C, D, E) of 
this strain were independently exposed to the antibiotic and a sixth isolate was 
left untreated for the 14 days (labeled U). A sample of each replicate was 
frozen at each 12-hour time-point. 
Figure 1. Graphical layout of the experimental design used to induce antibiotic 
resistance. K. pneumoniae was grown in low but increasing concentrations of the 
antibiotic cephalothin over a period of 14 days.
Minimum inhibitory concentrations (MICs) for susceptible and adapted isolates 
were then examined. Additionally, colony morphology changes were noted and 
their effects on MICs were investigated. To assess biofilm formation, K. 
pneumoniae was grown in a 96-well plate and planktonic bacteria were 
removed. The remaining adherent bacteria enveloped within biofilm were 
stained with crystal violet and quantified.
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Figure 2. Phenotypic morphology changes. Colonies of one treated replicate after 14 days of 
growth in cephalothin (14A) displayed large and small variants. Isolation of individual 
colonies gave rise to their respective phenotypes. Culturing individual colonies in media 
showcased further phenotypical differences in that large colony variants appeared to have 
large aggregates in culture whereas small colony variants in culture did not.
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• Induced cephalothin-resistant K. pneumoniae strains showed increased 
resistance to cephalothin, mild resistance to tetracycline and amikacin, 
and no change in resistance to kanamycin.
• A phenotypic change in colony morphology (large and small colonies) 
was observed in one treated replicate. For Day 14A, plates contained 
both small and large colonies. Individual colonies were isolated and 
showed the same but lower MIC 50s and breakpoints for cephalothin. 
However, once colonies were recombined, resistance was amplified.
• All isolates were able to produce biofilm. Day 0 was the weakest 
biofilm producer, and all Day 14 isolates (including the untreated 
condition) saw increases in biofilm production. 
Conclusions
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Figure 3. Biofilm-forming abilities of K. pneumoniae isolates. Cultures were grown and 
stained with crystal violet following the removal of planktonic bacteria to examine biofilm 
formation. Isolate numbers represent the day of isolation during the experiment, where A-E 
represent treated replicates and U represents the untreated condition. Error bars represent SD 
of the mean (n = 11).
Breakpoints 
in μg/mL Day 0
Day 
14U
Day 
14A
Day 
14B
Day 
14C
Day 
14D
Day 
14E
Cephalothin 8 4 31 62.5-125 31-62.5 31-62.5 31-62.5
Kanamycin 8 8-16 4 4 4 4 4
Tetracycline 4 8 8-16 8-31 16 16 16
Amikacin 31 31 16 16 8 4 62.5
Table 1. Breakpoints in μg/mL for starting and ending isolates. Day 0 was 
susceptible to cephalothin. All values represent concentrations of antibiotic (in μg/mL) 
needed to inhibit the growth of K. pneumoniae, where 14U represents the untreated 
control condition and A-E represent replicate conditions that were treated with 
cephalothin. 
Table 2. Minimum inhibitory concentrations of cephalothin for isolated and 
recombined 14A small and large colony variants. All values represent concentrations 
of antibiotic (in μg/mL) needed to inhibit the growth of K. pneumoniae, where 14U 
represents the untreated control condition and A-E represent replicate conditions that 
were treated with cephalothin. Cephalothin 
MICs in μg/mL MIC 50 Breakpoint
Small 8 16
Large 8 16
Recombined 31 62.5
Future Directions
Increased from 
original breakpoint of 
31 μg/mL
